Umang Nahata, Chief Executive Officer, Mastek, said, “Q4’FY26 our revenue has improved by 3.6% sequentially. This momentum is supported by 24.4% Y-o-Y growth in our 12-month order backlog, driven by continued strength in the UK and US Orderbook, improving revenue visibility. The UK business continues to lead our growth with 21.8% in INR Terms for FY26, driven by strong focus in healthcare, which grew by 95% Y-o-Y, complemented by new client wins in Financial Services. In North America, leading indicators are turning positive, supported by an execution-focused leadership team. While this market is still evolving, the strengthening pipeline provides confidence in a gradual recovery. Our Lead with AI strategy is now translating into measurable outcomes. During the quarter, we closed over 25 AI-assisted deals, taking the full-year total to 85+ deals. Our outcome focused drive on AI has helped deliver a 12% improvement in revenue per employee and helped sustain EBITDA margins at 16.1%. We have also strengthened our leadership depth with the appointment of a new Chief Financial Officer and Chief Human Resources Officer, reinforcing our capabilities to support the next phase of growth. FY26 has been a year of resetting our foundations – strengthening leadership, improving pipeline quality, and embedding AI-led efficiencies. With these building blocks in place, we are entering FY27 with improved visibility and a clear path to accelerated growth.”
